Covid-19 and remote patient monitoring for DMARDS and cancer

Covid-19 and remote patient monitoring

Remote patient monitoring and the use of digital technology to achieve this is an important part of the NHS Long Term Plan. But with the appearance of Covid-19 digital health has finally come of age, as the need to reduce face-to-face contact between clinicians and their patients has never been greater.

As medicine and clinicians’ expertise improves people with serious and life-limiting disease like cancer live longer. Away from hospital, free of treatment, living longer and more fulfilling lives. And with Covid-19 introducing unparalleled risks to clinicians and patients the need for ‘remoteness’ is greater than ever.

But reducing potential contact between clinicians and their patients introduces new risks. Risks that people living with serious conditions may be lost to the system. Those people need constant monitoring and remote surveillance to identify any problems that may reappear, but they at the same time they must not be lost sight of.

We’ve provided digital remote monitoring for years. It’s more relevant today than it’s ever been. That’s why we’re seeing increasing demand for our services. We can help clinicians and their patients using digital health technology. Technology like beetroot®.

Why beetroot®?

“I’m not sure how we would have identified our high risk patients without TAMonitor (beetrootDMARD). It will also allow some of us to work from home. It’s been an incredibly valuable tool for helping us to look after our patients during the epidemic.”

(work done to risk-stratify patients in response to the COVID-19 epidemic)

Dr Mark Lazarus, Consultant Rheumatologist, Southend University Hospital

Healthcare providers benefit from remote monitoring and improvingvulnerable patients’ wellbeing through a sophisticated but simple-to-use management interface in a cost-effective way.

Patients benefit from enhanced self-management by combining visibility of
their health data with personalised coaching from a rich knowledge base.

beetroot® is brought to you by THERAPYAUDIT Limited, which has many years’ experience in providing innovative software solutions to NHS, Public Health England and third sector clients in England. Our monitoring service has been collecting and analysing data for health professionals for years so we know a thing or two about making patient monitoring in the community work.

The beetroot® family

Digital monitoring of blood tests to provide patient safety. Currently deployed to 18 NHS hospitals in England. Some sites have used this service for over 20 years (read more…)

Next generation predictive monitoring to enhance the existing beetrootDMARD service. In development with Aston University and key customer clinicians. Utilising AI and machine learning to provide predictive rather than reactive monitoring.

A CCG-based version of beetrootDMARD providing a digital solution to the challenge of shared-care monitoring for GPs and secondary care clinicians. In pilot with one existing customer’s ‘local’ CCG (read more…)

Cloud-based data collection and audit to support community-based sexual health advice and contraception. Used by the majority of London Boroughs and other areas in England.

Cloud-based data collection of NHS HealthChecks. Used in pharmacies in London Borough of Barking and Dagenham. Planned for pilot in Sichuan province, China.

Portal-based collection of quality of life Patient Reported Outcome Measures from patients, and sharing of relevant data with patients, supporting beetrootDMARD and beetrootONCOLOGY services where patient interaction is required.

Cloud-based monitoring of diabetics and gestational diabetes. Integrated with SMS-based glucometers and WeChat and localised for pilot in China.

A digital hearing rehabilitation service including online screening, purchase of our hearing aid device, online calibration and support for the China and South Asia markets. Currently in development utilising funding from InnovateUK and Guangdong Science and Technology (read more…)